MLTX MoonLake Immunotherapeutics

Watchlist

Close Apr 26 16:00 ET

Post 16:20 ET

2.67BMarket Cap-58205P/E (TTM)

MoonLake Immunotherapeutics Stock Analyst Ratings & Price Target

Updated: Apr 9, 2024

Based on 14 analysts giving stock ratings to MoonLake Immunotherapeutics in the past 3 months

Strong Buy

Updated: Apr 9, 2024

The average MoonLake Immunotherapeutics stock price target is 73.08 with a max estimate of 100.00 and a min estimate of 55.00

Review MoonLake Immunotherapeutics earnings estimates

Receive timely notifications of rating changes

View more detailed ratings of institutions and analysts

View rating details page for historical data

Download APP

Analyst Ratings Disclaimer

Updated: Apr 9, 2024

Strong Buy

Updated: Apr 9, 2024

Overall